Indo Count Industries (ICIL) - Detailed Equity Research Report

1. Executive Summary & Verdict

• Verdict: UNLIKELY (Score: 42/100)
• Fundamental Grade: C (Minervini SEPA: Trailing earnings experienced a 55% YoY drop in FY26; Q1 FY27 displays strong rebound, but return metrics remain suppressed).
• As-Of Price: ₹423.2 | Market Cap: ₹8,431 Cr | Trailing P/E: 66.2x
• Catalyst Evaluation: Q1 FY27 revenue reached ₹1,224 Cr (+26.5% YoY) and PAT reached ₹63 Cr (+62% YoY), driven by scaling in the 'New Business' segment (33% of revenue). Company reaffirmed FY27 revenue guidance of ₹5,500 Cr.
• Thesis Summary: While Q1 FY27 confirms an operational turnaround following a weak FY26 (PAT ₹127 Cr vs ₹276 Cr in FY25), the stock has already rallied 49.3% in 3 months and 75.8% in 12 months. The FY27 growth target of ₹5,500 Cr was already disclosed in May/June 2026 filings (already_priced_in: true). With ROCE at 9.0%, heavy reliance on the US market (61% revenue), high client concentration (top 5 = 47%), and ongoing US tariff uncertainties, the stock offers limited re-rating upside from current valuations.

2. Industry Context & Quality Gate Evaluation

• Industry: Textiles - Home Textiles / Bed Linen
• Capital Intensity: Medium (requires processing/weaving capacity + ongoing working capital for global inventory management).
• Expected Industry CAGR: ~6.0% - 7.0%
• Quality Gate Verdict: FAILED. Trailing ROCE is 9.0% (threshold 15%), reflecting depressed earnings in FY26 due to inventory rationalization and incubation costs of US manufacturing. The industry is mature and subject to foreign trade policy risks.

3. Catalyst & Ramp-Aware Impact Math

• TTM Base Financials: Revenue = ₹4,142 Cr, PAT = ₹127 Cr, EPS = ₹6.39.
• Guidance Target: FY27 Revenue of ₹5,500 Cr (~32.8% growth over TTM).
• Margin & Profit Projections:
• At ₹5,500 Cr revenue and guided EBITDA margin of ~13.0%, Consolidated EBITDA = ₹715 Cr.
• Subtracting Depreciation (~₹120 Cr), Finance Costs (~₹60 Cr), and Taxes (~25%), projected FY27 PAT = ₹380 - ₹400 Cr.
• Projected FY27 EPS = ~₹19.2 - ₹20.2 per share.
• Valuation Impact:
• At current price of ₹423.2, forward FY27 P/E is ~21x - 22x.
• Given peer median P/E of ~18.8x, the market is already valuing ICIL at a fair multiple relative to its historical return metrics.

4. Fundamental & Minervini Quality Check

• Quarterly Momentum: Q1 FY27 showed a sharp turnaround (PAT ₹63 Cr vs Q4 FY26 PAT ₹24 Cr). However, FY26 annual net profit fell from ₹276 Cr in FY25 to ₹127 Cr in FY26.
• Debt & Balance Sheet: Debt sits at ₹824 Cr against Net Worth of ₹2,317 Cr (D/E 0.36). Working capital utilization was ~70% over the last 12 months.
• Promoter Alignment: Stable promoter holding at 58.74% with zero pledge.

5. Scenario Analysis & Price Targets

• Base Case (12-24m): Revenue reaches ₹5,500 Cr in FY27 and ₹6,000 Cr in FY28. EPS stabilizes at ₹20.0 - ₹22.0. Applying a forward P/E of 23x yields a price target of ₹508 (+20% upside).
• Bull Case (12-24m): US manufacturing ramps up rapidly above 80% utilization; tariff risks subside; EBITDA margin expands to 14.5%; FY28 EPS reaches ₹25.5. At 24x P/E, price target is ₹612 (+45% upside).
• Bear Case (12-24m): Higher US tariffs (50%) compress margins; big-box customer destocking hits volume growth; EBITDA margin drops back to 10.0%; EPS stalls at ₹14.0. At 22x P/E, stock drops to ₹318 (-25% downside).

6. Verdict Rationale

1. News Already Discounted: The target of ₹5,500 Cr revenue for FY27 was previously communicated in May/June 2026. The stock's 50% 3-month rally has largely priced in the earnings recovery.
2. Concentration & Geopolitical Risk: 61% revenue dependency on the US and potential 50% tariff exposures present persistent structural risks.
3. Return Ratios: Sub-10% ROCE prevents treating ICIL as a high-quality compounder, capping its multibagger potential.